BCHE and Alzheimer disease: Although no FDA-approved treatments exist for VaD, cholinesterase inhibitors such as donepezil, galantamine, and rivastigmine, and N-methyl-D-aspartate (NMDA) receptor antagonists such as memantine, which are occasionally used to treat AD, are primarily administered because some patients with VaD also show AD symptoms.